Matches in SemOpenAlex for { <https://semopenalex.org/work/W2995512400> ?p ?o ?g. }
- W2995512400 endingPage "1028.e8" @default.
- W2995512400 startingPage "1016" @default.
- W2995512400 abstract "Background & AimsIrritable bowel syndrome (IBS) is a heterogeneous disorder, but diagnoses and determination of subtypes are made based on symptoms. We profiled the fecal microbiomes of patients with and without IBS to identify biomarkers of this disorder.MethodsWe collected fecal and urine samples from 80 patients with IBS (Rome IV criteria; 16–70 years old) and 65 matched individuals without IBS (control individuals), along with anthropometric, medical, and dietary information. Shotgun and 16S ribosomal RNA amplicon sequencing were performed on feces, whereas urine and fecal metabolites were analyzed by gas chromatography and liquid chromatography–mass spectrometry. Co-occurrence networks were generated based on significant Spearman correlations between data. Bile acid malabsorption (BAM) was identified in patients with diarrhea by retention of radiolabeled selenium-75 homocholic acid taurine.ResultsPatients with IBS had significant differences in network connections between diet and fecal microbiomes compared with control individuals; these were accompanied by differences in fecal metabolomes. We did not find significant differences in fecal microbiota composition among patients with different IBS symptom subtypes. Fecal metabolome profiles could discriminate patients with IBS from control individuals. Urine metabolomes also differed significantly between patients with IBS and control individuals, but most discriminatory metabolites were related to diet or medications. Fecal metabolomes, but not microbiomes, could distinguish patients with IBS with vs those without BAM.ConclusionsDespite the heterogeneity of IBS, patients have significant differences in urine and fecal metabolomes and fecal microbiome vs control individuals, independent of symptom-based subtypes of IBS. Fecal metabolome analysis can be used to distinguish patients with IBS with vs those without BAM. These findings might be used for developing microbe-based treatments for these disorders. Irritable bowel syndrome (IBS) is a heterogeneous disorder, but diagnoses and determination of subtypes are made based on symptoms. We profiled the fecal microbiomes of patients with and without IBS to identify biomarkers of this disorder. We collected fecal and urine samples from 80 patients with IBS (Rome IV criteria; 16–70 years old) and 65 matched individuals without IBS (control individuals), along with anthropometric, medical, and dietary information. Shotgun and 16S ribosomal RNA amplicon sequencing were performed on feces, whereas urine and fecal metabolites were analyzed by gas chromatography and liquid chromatography–mass spectrometry. Co-occurrence networks were generated based on significant Spearman correlations between data. Bile acid malabsorption (BAM) was identified in patients with diarrhea by retention of radiolabeled selenium-75 homocholic acid taurine. Patients with IBS had significant differences in network connections between diet and fecal microbiomes compared with control individuals; these were accompanied by differences in fecal metabolomes. We did not find significant differences in fecal microbiota composition among patients with different IBS symptom subtypes. Fecal metabolome profiles could discriminate patients with IBS from control individuals. Urine metabolomes also differed significantly between patients with IBS and control individuals, but most discriminatory metabolites were related to diet or medications. Fecal metabolomes, but not microbiomes, could distinguish patients with IBS with vs those without BAM. Despite the heterogeneity of IBS, patients have significant differences in urine and fecal metabolomes and fecal microbiome vs control individuals, independent of symptom-based subtypes of IBS. Fecal metabolome analysis can be used to distinguish patients with IBS with vs those without BAM. These findings might be used for developing microbe-based treatments for these disorders." @default.
- W2995512400 created "2019-12-26" @default.
- W2995512400 creator A5011576603 @default.
- W2995512400 creator A5015909472 @default.
- W2995512400 creator A5021305130 @default.
- W2995512400 creator A5040336306 @default.
- W2995512400 creator A5042084879 @default.
- W2995512400 creator A5045261563 @default.
- W2995512400 creator A5061602285 @default.
- W2995512400 creator A5067002957 @default.
- W2995512400 creator A5078442503 @default.
- W2995512400 creator A5082880297 @default.
- W2995512400 creator A5085126378 @default.
- W2995512400 creator A5089846907 @default.
- W2995512400 date "2020-03-01" @default.
- W2995512400 modified "2023-10-14" @default.
- W2995512400 title "Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption" @default.
- W2995512400 cites W1597285948 @default.
- W2995512400 cites W1861519250 @default.
- W2995512400 cites W1966327575 @default.
- W2995512400 cites W1971061059 @default.
- W2995512400 cites W1973372499 @default.
- W2995512400 cites W1983812599 @default.
- W2995512400 cites W1989500692 @default.
- W2995512400 cites W1994154508 @default.
- W2995512400 cites W2001561488 @default.
- W2995512400 cites W2011312755 @default.
- W2995512400 cites W2022076927 @default.
- W2995512400 cites W2022110523 @default.
- W2995512400 cites W2028719601 @default.
- W2995512400 cites W2031466583 @default.
- W2995512400 cites W2036258026 @default.
- W2995512400 cites W2038100201 @default.
- W2995512400 cites W2040223383 @default.
- W2995512400 cites W2044080542 @default.
- W2995512400 cites W2052082457 @default.
- W2995512400 cites W2057317924 @default.
- W2995512400 cites W2058506963 @default.
- W2995512400 cites W2059417056 @default.
- W2995512400 cites W2063653508 @default.
- W2995512400 cites W2064201279 @default.
- W2995512400 cites W2066299684 @default.
- W2995512400 cites W2075530811 @default.
- W2995512400 cites W2088833470 @default.
- W2995512400 cites W2093464846 @default.
- W2995512400 cites W2103658609 @default.
- W2995512400 cites W2104251890 @default.
- W2995512400 cites W2109606373 @default.
- W2995512400 cites W2113582196 @default.
- W2995512400 cites W2123812491 @default.
- W2995512400 cites W2124351063 @default.
- W2995512400 cites W2128769815 @default.
- W2995512400 cites W2136879569 @default.
- W2995512400 cites W2146292423 @default.
- W2995512400 cites W2157107905 @default.
- W2995512400 cites W2166102321 @default.
- W2995512400 cites W2166281097 @default.
- W2995512400 cites W2170178906 @default.
- W2995512400 cites W2194591433 @default.
- W2995512400 cites W2211117827 @default.
- W2995512400 cites W2238097650 @default.
- W2995512400 cites W2283285523 @default.
- W2995512400 cites W2314167679 @default.
- W2995512400 cites W2336553033 @default.
- W2995512400 cites W2342540743 @default.
- W2995512400 cites W2398316059 @default.
- W2995512400 cites W2530691947 @default.
- W2995512400 cites W2550352184 @default.
- W2995512400 cites W2552041992 @default.
- W2995512400 cites W2559597060 @default.
- W2995512400 cites W2624106029 @default.
- W2995512400 cites W2733086591 @default.
- W2995512400 cites W2754724391 @default.
- W2995512400 cites W2762906919 @default.
- W2995512400 cites W2799539744 @default.
- W2995512400 cites W2807927929 @default.
- W2995512400 cites W2883916703 @default.
- W2995512400 cites W2884024979 @default.
- W2995512400 cites W2889477263 @default.
- W2995512400 cites W2896437365 @default.
- W2995512400 cites W2897611961 @default.
- W2995512400 cites W2898363902 @default.
- W2995512400 cites W2903882846 @default.
- W2995512400 cites W2910423505 @default.
- W2995512400 doi "https://doi.org/10.1053/j.gastro.2019.11.301" @default.
- W2995512400 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31843589" @default.
- W2995512400 hasPublicationYear "2020" @default.
- W2995512400 type Work @default.
- W2995512400 sameAs 2995512400 @default.
- W2995512400 citedByCount "112" @default.
- W2995512400 countsByYear W29955124002020 @default.
- W2995512400 countsByYear W29955124002021 @default.
- W2995512400 countsByYear W29955124002022 @default.
- W2995512400 countsByYear W29955124002023 @default.
- W2995512400 crossrefType "journal-article" @default.
- W2995512400 hasAuthorship W2995512400A5011576603 @default.
- W2995512400 hasAuthorship W2995512400A5015909472 @default.
- W2995512400 hasAuthorship W2995512400A5021305130 @default.